Abstract
New Ru(II) polypyridyl complexes containing two intercalative ligands, [Ru(dppz)2phen]2+ (1) (dppz=dipyrido-[3,2-a:2′,3′-c]phenazine, phen=1,10-phenanthroline) and [Ru(dppz)2dpq]2+ (2) (dpq=di-pyrido[3,2-f:2′,3′-h]quinoxaline) have been synthesized and characterized. The binding of both complexes with calf thymus DNA (CT-DNA) has been investigated by spectroscopic and viscosity measurement. Results indicate that complexes 1 and 2 bind to DNA through intercalation, and the DNA binding affinity of complex 2 is much stronger than that of complex 1. However, the equilibrium binding constants of both complexes with DNA are smaller than that of [Ru(phen)2(dppz)]2+ and [Ru(bpy)2(dppz)]2+ (bpy=2,2´-bipyridine) with one intercalative ligand, which may be interpreted by the steric hindrance effect of the two intercalated ligand dppz. On the other hand, comparing complex 1 with complex 2, the former can serve as a molecular “light switch” for DNA, and this difference may be due to the different ancillary ligands in complexes 1 and 2. In addition, both complexes demonstrate different antitumor activities against selected tumor cell lines in vitro, and can make the cells apoptosis.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
